NexPoint Real Estate Finance, Inc. Announces Second Quarter 2026 Earnings Conference Call
Get Alerts NREF Hot Sheet
Join SI Premium – FREE
The conference call can be accessed live over the phone by dialing 833-461-5787 or, for international callers, +1 365-657-4084 and using passcode Conference ID: 492 613 888. A live audio webcast of the call will be available online at the Company's website, nref.nexpoint.com (under "Resources"). An online replay will be available shortly after the call on the Company's website and continue to be available for 60 days.
The Company plans to issue a press release with second quarter 2026 financial results before market open on
About NexPoint Real Estate Finance, Inc.
NexPoint Real Estate Finance, Inc., is a publicly traded REIT, with its common stock and Series A Preferred Stock listed on the New York Stock Exchange under the symbols "NREF" and "NREF-PRA," respectively, primarily focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties and common equity investments, as well as multifamily and single-family rental commercial mortgage-backed securities securitizations, promissory notes, revolving credit facilities and stock warrants. More information about the Company is available at nref.nexpoint.com.
CONTACTS
Investor Relations
Kristen Griffith
[email protected]
Media Relations
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/nexpoint-real-estate-finance-inc-announces-second-quarter-2026-earnings-conference-call-302822190.html
SOURCE NexPoint Real Estate Finance, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Marquis Who's Who Honors Francois M. de Visscher for Decades-Long Work in Family Business Advisory and Diplomacy
- Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share